Hims & Hers (HIMS) made a killing last year selling an off-brand version of Ozempic, but with the drug’s shortage now over, ...

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

Using the database below, you can track changes in the average price pharmacies pay for prescription drugs. To find the ...

Congressmen Don Davis (NC-01) and August Pfluger (TX-11) introduced H.R. 1244, the Reducing Drug Prices for Seniors Act, a ...

Discover the growing use of RFID technology in U.S. hospitals and its potential to improve medication management, efficiency, and safety. Learn more here.

A new mathematical model developed at the University of Waterloo can determine a baby's overall drug exposure when their ...

The pharma giant will now offer 7.5mg and 10mg dosages of Zepbound, as well as lower rates for its 2.5mg and 5mg vials.

Eli Lilly announced a price reduction for its weight-loss drug Zepbound's vials by $50 or more, adapting to stiff competition ...

GenBioPro, a leading manufacturer of abortion medication, is preparing to go to battle with the Trump administration.

PBMs act as intermediaries between insurance providers and pharmacies. They determine how much patients pay out of pocket for ...

The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...

Eli Lilly has reduced the price of its weight-loss drug, Zepbound, to combat competition from compounding pharmacies and Novo ...